Notably, SERPINE1 emerges as a dependable prognostic biomarker across various cancer types, including colon [8], breast [9], pancreatic [10], bladder [11], non‐small cell lung [12], and low‐grade gliomas [13]. Here, SERPINE1 is linked to cancer.